COVID-19 Records

Ralph,

Baric Transcribed Interview (Redacted), pp.148-149 · baric_ti:email:00004

Page text: p.148, p.149 · original PDF

Date
— (unknown precision)
Type
email · email
Menachery, Vineet (J ©UTMB.EDU) 3/7/2019 11:46:47 PM Baric, Ralph S [rbaric@email.unc.edu] Paul Leon [J @autonomoustherapeutics.com]; Timothy Notton [fj @autonomoustherapeutics.com]; Ariel Weinberger iJ @autonomoustherapeutics.com]; Baric, Toni C [IEP med.unc.edu) DARPA Project T have been working on a DARPA proposal with Autonomous Therapeutics on MERS-CoV with a quick turn around. Ariel and Pau (CCed) are funded for another DARPA project to generate therapeutic interferring particles and are looking to apply their approach for MERS on this specific supplement call. We have been chatting for a few weeks and they are interested in both in vitro and in vivo experiments with their MERSCoV targeted TIPs. I am currently planning to work with them on the in vitro side, but suggested they talk directly with you about the DPP4 288/330 model. T do not think my lab has the capacity to do the in vivo mouse experiments and they prefer the 288/330 model. If the TIPs work in mice, we would extend the work to marmosets at UTMB. They will contact you directly and I know they are on a short turn around time; I cced Toni as well to see if you'd have time in your schedule, I'll be doing harvests in the morning, so no need to include me on any of the calls. Thanks VDM 'irst tried

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. — unattributed
    Menachery, Vineet (J ©UTMB.EDU) 3/7/2019 11:46:47 PM Baric, Ralph S [rbaric@email.unc.edu] Paul Leon [J @autonomoustherapeutics.com]; Timothy Notton [fj @autonomoustherapeutics.com]; Ariel Weinberger iJ @autonomoustherapeutics.com]; Baric, Toni C [IEP med.unc.edu) DARPA Project T have been working on a DARPA proposal with Autonomous Therapeutics on MERS-CoV with a quick turn around. Ariel and Pau (CCed) are funded for another DARPA project to generate therapeutic interferring particles and are looking to apply their approach for MERS on this specific supplement call. We have been chatting for a few weeks and they are interested in both in vitro and in vivo experiments with their MERSCoV targeted TIPs. I am currently planning to work with them on the in vitro side, but suggested they talk directly with you about the DPP4 288/330 model. T do not think my lab has the capacity to do the in vivo mouse experiments and they prefer the 288/330 model. If the TIPs work in mice, we would extend the work to marmosets at UTMB. They will contact you directly and I know they are on a short turn around time; I cced Toni as well to see if you'd have time in your schedule, I'll be doing harvests in the morning, so no need to include me on any of the calls. Thanks VDM 'irst tried

Full conversation →